Drexler, I;Staib, C;Sutter, G
Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?
Curr Opin Biotechnol
2004
15
6
506-12

Olszewska, W;Suezer, Y;Sutter, G;Openshaw, PJ
Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins.
Vaccine
2004
23
2
215-21

Koopman, G;Mortier, D;Hofman, S;Niphuis, H;Fagrouch, Z;Norley, S;Sutter, G;Liljeström, P;Heeney, JL
Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens.
J Gen Virol
2004
85
Pt 10
2915-24

Staib, C;Drexler, I;Sutter, G
Construction and isolation of recombinant MVA.
Methods Mol Biol
2004
269
77-100

Herrmann, F;Lehr, HA;Drexler, I;Sutter, G;Hengstler, J;Wollscheid, U;Seliger, B
HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway.
Cancer Res
2004
64
1
215-20

Lotz, C;Ferreira, EA;Drexler, I;Mutallib, SA;Huber, C;Sutter, G;Theobald, M
Partial tyrosinase-specific self tolerance by HLA-A*0201-restricted cytotoxic T lymphocytes in mice and man.
Int J Cancer
2004
108
4
571-9

Mäkitalo, B;Lundholm, P;Hinkula, J;Nilsson, C;Karlén, K;Mörner, A;Sutter, G;Erfle, V;Heeney, JL;Wahren, B;Biberfeld, G;Thorstensson, R
Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen.
J Gen Virol
2004
85
Pt 8
2407-19

Hultström, AL;Bratt, G;Cosma, A;Erfle, V;Wahren, B;Carbone, E
Autologous cytotoxicity of natural killer cells derived from HIV-infected patients.
Immunol Lett
2004
91
2-3
155-8

Cosma, A;Bühler, S;Nagaraj, R;Staib, C;Hammarin, AL;Wahren, B;Goebel, FD;Erfle, V;Sutter, G
Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.
Clin Diagn Lab Immunol
2004
11
2
406-10

Priola, SA;Vorberg, I
Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies.
Methods Mol Biol
2004
268
517-40